Treatment of picornavirus infections

被引：92

作者：

Rotbart, HA

机构：

[1] Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA

[2] Univ Colorado, Sch Med, Dept Microbiol, Denver, CO 80262 USA

来源：

ANTIVIRAL RESEARCH | 2002年 / 53卷 / 02期

关键词：

picornavirus; therapy; prophylaxis; rhinovirus; enterovirus;

D O I：

10.1016/S0166-3542(01)00206-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The picornaviruses are a diverse group of viral pathogens that together comprise the most common causes of infections of humans in the developed world. Within the picornavirus family are three well-known groups of human pathogens-the enteroviruses (including polioviruses, coxsackieviruses, and echoviruses), the rhinoviruses, and the hepatoviruses (including hepatitis A). Recently, the parechoviruses (formerly, echoviruses 22 and 23) have been classified as a fourth genus of human picornaviruses. This article will focus on the enteroviruses and rhinoviruses agents, for which substantial effort has been expended and recent successes reported towards the development of safe and effective antiviral therapy. (C) 2002 Published by Elsevier Science B.V.

引用

页码：83 / 98

页数：16

共 117 条

[21]

DALAKAS MC, 1984, REV INFECT DIS, V6, pS562

[22]

DELONG DC, 1978, 78 ANN M AM SOC MICR, P234

[23]

DELONG DC, 1978, 18 INT C ANT AG CHEM

[24]

DICK EC, 1968, P SOC EXP BIOL MED, V127, P1079, DOI 10.3181/00379727-127-32875